Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate

Author： Klar Ulrich   Hoffmann Jens   Giurescu Marius  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.11, 2008-11, pp. : 1735-1748

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a virosomal malaria vaccine candidate: from synthetic peptide design to clinical concept validation

By Pluschke Gerd   Tamborrini Marco  

Future Virology, Vol. 7, Iss. 8, 2012-08 ,pp. : 779-790

Future Medicine

Access to resources Recommend Favorite

The Development of the Antitumour Benzothiazole Prodrug, Phortress, as a Clinical Candidate

By  

Current Medicinal Chemistry, Vol. 11, Iss. 8, 2004-04 ,pp. : 1009-1021

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 1, 2002-03 ,pp. : 79-83

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Product Guided Compound Library Development

By  

Current Medicinal Chemistry, Vol. 9, Iss. 23, 2002-12 ,pp. : 2129-2145

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical and clinical results with the natural marine product ET-743

By D’Incalci Maurizio   Jimeno José  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1843-1853

Informa Healthcare

Access to resources Recommend Favorite